Interleukin-31 promotes pathogenic mechanisms underlying skin and lung fibrosis in scleroderma.
Yaseen B, Lopez H, Taki Z, Zafar S, Rosario H, Abdi BA, Vigneswaran S, Xing F, Arumalla N, Black S, Ahmad S, Kumar K, Gul R, Scolamiero L, Morris S, Bowman A, Stainer A, Rice A, Stock C, Renzoni E, Denton CP, Venturini C, Brown M, O'Reilly S, Stratton R.
Yaseen B, et al. Among authors: stock c.
Rheumatology (Oxford). 2020 Sep 1;59(9):2625-2636. doi: 10.1093/rheumatology/keaa195.
Rheumatology (Oxford). 2020.
PMID: 32365362